Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.9100
-0.0900 (-9.00%)
At close: May 12, 2026, 4:00 PM EDT
0.9300
+0.0200 (2.20%)
After-hours: May 12, 2026, 5:58 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $202.04 million as of May 12, 2026. Its market cap has decreased by -9.55% in one year.
Market Cap
202.04M
Enterprise Value
229.67M
1-Year Change
-9.55%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $202.04M, an increase of 62.53%. That is a compound annual growth rate of 9.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 222.02M | 19.77% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adagene | 243.81M |
| Orchestra BioMed Holdings | 241.92M |
| OmniAb | 240.65M |
| Fennec Pharmaceuticals | 240.56M |
| Keros Therapeutics | 238.84M |
| Milestone Pharmaceuticals | 235.49M |
| Alector | 233.15M |
| Sol-Gel Technologies | 231.64M |